Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
- Conditions
- Advanced CancerMetastatic Solid Tumor
- Interventions
- First Posted Date
- 2021-08-13
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 77
- Registration Number
- NCT05004116
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Radiation: Radiation Therapy
- First Posted Date
- 2021-08-09
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 91
- Registration Number
- NCT04997018
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸Victoria Brennan, Uniondale, New York, United States
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
- Conditions
- Lung Cancer Stage IILung CancerLung Cancer Stage III
- Interventions
- First Posted Date
- 2021-08-05
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT04991025
- Locations
- 🇺🇸
Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Fluorescent Imaging of Nerves with Illuminare-1 During Surgery
- Conditions
- Prostate Adenocarcinoma
- Interventions
- Device: Karl Storz D-Light C photodynamic diagnostic (PDD)
- First Posted Date
- 2021-07-30
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT04983862
- Locations
- 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)
- Conditions
- Metastatic Non Small Cell Lung CancerRecurrent Non Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2021-07-16
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 43
- Registration Number
- NCT04965090
- Locations
- 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Nassau, Uniondale, New York, United States
Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome
- Conditions
- Mycosis FungoidesMycosis Fungoides/Sezary SyndromeSezary SyndromeSézaryAdvanced Mycosis Fungoides
- Interventions
- First Posted Date
- 2021-07-14
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 28
- Registration Number
- NCT04960618
- Locations
- 🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
A Study of N9 Chemotherapy in Children With Neuroblastoma
- Conditions
- Pediatric CancerNeuroblastoma
- Interventions
- First Posted Date
- 2021-07-01
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 26
- Registration Number
- NCT04947501
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- Conditions
- Solid Tumor, Unspecified, AdultSolid TumorSolid Tumor, Adult
- Interventions
- Behavioral: CONVO intervention
- First Posted Date
- 2021-06-28
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 234
- Registration Number
- NCT04942717
- Locations
- 🇺🇸
SBH Health System, Bronx, New York, United States
🇺🇸Jacobi Medical Center, Bronx, New York, United States
🇺🇸New York Cancer & Blood Specialists (Data collection only), Bronx, New York, United States
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- Conditions
- Neuroblastoma
- Interventions
- First Posted Date
- 2021-06-23
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 286
- Registration Number
- NCT04936529
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
- Conditions
- Primary Extra-cranial Solid TumorRecurrent or Refractory Glypican 3 (GPC3)
- Interventions
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT04928677
- Locations
- 🇺🇸
Children's Hospital of Los Angeles (Data Collection Only), Los Angeles, California, United States
🇺🇸Dana Farber Cancer Institute (Data Collection Only), Boston, Massachusetts, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States